Sativa Wellness Group Inc., formerly Stillcanna Inc., (the Company) announces that, further to the completion of its recommended share-for-share exchange offer for Sativa Group plc which was implemented by means of a court-sanctioned scheme of arrangement under Part 26 of the Companies Act 2006, and which became effective on 3 September 2020, the Company has duly confirmed in writing to the Panel on Takeovers And Mergers (“Panel”) in the UK in accordance with the requirements of Rule 19.6(c) of the City Code on Takeovers and Mergers (“Code”).

Sativa Wellness Group Inc. is pleased to announce today that it has signed a distribution agreement with German partners Lexamed GMBH (“Lexamed”). This exclusive agreement will allow both parties to work together to build the Goodbody CBD brand within Germany with plans to expand this to other European countries in the future.

Sativa Wellness Group Inc. is pleased to announce today its first quarterly profit in Q2 2021. The Company has filed the Financial Statements and Management’s Discussion and Analysis for Q2 June 2021 with exceptionally strong results which demonstrates the continued growth.

Sativa Wellness is pleased to announce its new business strategy following a strong start to the year.

The Company announces that Marc Howells, Chief Executive Officer, has been awarded 1,447,173 options yesterday over 1,447,173 Common Shares of the Company (“Director Options”). The Director Options vest immediately, have an exercise price of 6.2 cents and are valid for 5 years.

Sativa Wellness Group Inc. is pleased to announce that today it will open its 40th clinic, and that it is also expected to list shortly through Patient Access.

Sativa Wellness Group Inc. is pleased to announce that following its collaboration with King’s College London, investigating the potential therapeutic use of cannabinoids for the treatment of respiratory diseases, a research paper including the results of part of this research has been published.

The Company announces that in accordance with the Financial Conduct Authority’s Disclosure and Transparency Rules (the “Disclosure and Transparency Rules”), the total number of common shares of nil par value in the capital of the Company in issue as at the date of this notice is 364,615,913 with each share carrying the right to one vote.

Sativa Wellness Group Inc. is pleased to announce that it has filed the Financial Statements and Management’s Discussion and Analysis for Q1 March 2021. All amounts unless stated otherwise are presented in British Pounds (GBP).

The Company has maintained its presence within the CBD sector producing both quality isolate and distillate in Poland for the CBD market as well as continuing to produce a range of quality end products through its ‘Goodbody’ brand in the UK.